Insider selling is routine and not actionable. Monitor upcoming earnings for any fundamental changes, but no immediate trading signal from this cluster.
EBS drugs
EBS drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Apr 30 $8.23entry
- T+1 · 7mo ago +2.92%α +2.70% · $8.47
- T+5 · 6mo ago +10.57%α +8.84% · $9.10
- T+20 · 6mo ago +11.54%α +6.58% · $9.18
- T+60 · 4mo ago −10.94%α −14.04% · $7.33
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three directors of Emergent BioSolutions sold a total of approximately $385K in open-market shares over two days, representing less than 0.1% of market cap. This is routine insider selling, not indicative of material concerns, especially given concurrent non-cash stock grants to the same directors.
Key Financial Metrics
Key Facts
- 3 directors sold shares: Katkin Keith ($128K), DeGolyer Donald W ($121K), Zoon Kathryn C ($135K)
- Total open-market sales: ~$385K, ~0.09% of $437M market cap
- All sales occurred at ~$8.28-$8.36 per share on April 30 and May 1, 2026
- Multiple directors also received non-cash stock grants (A) on April 30, 2026
Financial Impact
Total insider sales of $385K are trivial relative to $437M market cap
Risk Factors
- Further insider selling if negative news emerges
- No C-suite participation reduces signal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-EBS-1777930260656 |
Track record
23 reports on EBS
4 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +14.89% at T+20 after the Apr 29, 2026 report. 4 of 5 went positive at some point.
Filters
- Nov 16, 2026today Institutional Cluster Neutral 3/10 Entry $5.76 Now $5.81 +0.96% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.75 Now $5.81 +1.13% settles Nov 23
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $5.79 Now $5.81 +0.35% settles Nov 23
- Nov 4, 202612d ago 8-K Neutral 4/10 Entry $5.85 to $5.89 Now $5.81 −0.68% ▲ +0.68% −2.61% vs SPY
- Nov 2, 202614d ago 8-K Bearish 6/10 Entry $6.25 to $6.05 Now $5.81 +7.04% ▲ +3.20% +2.61% vs SPY
- Oct 30, 202617d ago Institutional Cluster Neutral 2/10 Entry $6.81 to $6.06 Now $5.81 −14.68% ▼ −11.01% −8.31% vs SPY
- Oct 16, 20264w ago 8-K Neutral 3/10 Entry $6.38 to $6.23 Now $5.81 −8.93% ▼ −2.35% −2.44% vs SPY
- Oct 7, 20265w ago 144 Neutral 2/10 Entry $6.81 to $7.18 Now $5.81 −14.68% ▲ +5.43% +5.71% vs SPY
- Jun 29, 202620w ago 8-K Bullish 5/10 Entry $8.46 to $8.18 Now $5.81 −31.32% ▼ −3.31% −4.70% vs SPY
- Jun 4, 202623w ago Press Release Neutral 2/10 Entry $8.44 to $8.39 Now $5.81 −31.16% ▼ −0.59% +1.96% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers